Advertisement
New Zealand markets closed
  • NZX 50

    11,741.47
    -21.85 (-0.19%)
     
  • NZD/USD

    0.6094
    -0.0007 (-0.12%)
     
  • ALL ORDS

    7,959.50
    +42.40 (+0.54%)
     
  • OIL

    78.37
    -0.17 (-0.22%)
     
  • GOLD

    2,044.70
    +2.00 (+0.10%)
     

Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy?

Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy?

Electronic health records say tirzepatide, the active ingredient in Mounjaro and Zepbound, is better at reducing weight than semaglutide, the active ingredient in Ozempic and Wegovy.